This inventor holds 3 USPTO granted patents, plus 2 CIPO patents. Top assignees: Gist-Brocades N.v., Royal Gist-Brocades N.v.. Active years: 1993-1998.
Location History:
- Ontario, CA (1993)
- Brampton, CA (1996 - 1998)
Company Filing History:
Years Active: 1993-1998
Title: Mark Hudson Pickett: Innovator in Filamentous Fungi Technology
Introduction
Mark Hudson Pickett is a notable inventor based in Brampton, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of vectors for use in filamentous fungi. With a total of 3 patents to his name, his work has advanced the understanding and application of protein expression in fungal hosts.
Latest Patents
One of Mark Hudson Pickett's latest patents focuses on novel vectors for use in filamentous fungi, specifically Aspergillus species. These vectors allow for the insertion of protein coding regions, enabling the expression or secretion of the coded proteins from the host. The patent also discloses valuable signal peptide sequences and promoter sequences that facilitate this process. By providing filamentous fungi with foreign or natural coding regions associated with appropriate promoter sequences, the invention enhances the control over protein expression and secretion.
Career Highlights
Throughout his career, Mark Hudson Pickett has worked with prominent companies in the biotechnology sector, including Gist-Brocades N.V. and Royal Gist-Brocades N.V. His experience in these organizations has contributed to his expertise in the field and has allowed him to collaborate with other professionals in the industry.
Collaborations
Some of Mark Hudson Pickett's notable coworkers include David Ivor Gwynne and Francis Paul Buxton. Their collaborative efforts have likely played a role in advancing the research and development of innovative biotechnological solutions.
Conclusion
Mark Hudson Pickett's contributions to the field of filamentous fungi technology demonstrate his commitment to innovation and advancement in biotechnology. His patents and collaborations reflect a dedication to enhancing protein expression methods, which can have significant implications for various applications in science and industry.